Transfusion-related acute lung injury risk mitigation: an update.

about

Transfusion-related acute lung injury risk mitigation: an update.

Item

http://www.wikidata.org/entity/Q47628286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Transfusion-related acute lung injury risk mitigation: an update.

@en

Transfusion-related acute lung injury risk mitigation: an update.

@nl

type

Item

label

Transfusion-related acute lung injury risk mitigation: an update.

@en

Transfusion-related acute lung injury risk mitigation: an update.

@nl

prefLabel

Transfusion-related acute lung injury risk mitigation: an update.

@en

Transfusion-related acute lung injury risk mitigation: an update.

@nl

P1476

Transfusion-related acute lung injury risk mitigation: an update.

@en

P2093

C Liu

http://www.w3.org/2001/XMLSchema#string

Z K Otrock

http://www.w3.org/2001/XMLSchema#string

P2860

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury.

Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).

The efficacy of synthetic media in the storage of human platelets for transfusion.

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.

Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors

Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).

Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study.

Identification of specificities of antibodies against human leukocyte antigens in blood donors.

How much residual plasma may cause TRALI?

P304

694-703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VOX.12573

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Brenda J. Grossman

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28948604

http://www.w3.org/2001/XMLSchema#string